Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 

Global Ventricular Arrhythmia API Manufacturers, Marketed and Phase III Drugs Landscape Report 2017-2018 - Research and Markets

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/17/2017 | 07:52pm CET

Research and Markets has announced the addition of the "Ventricular Arrhythmia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" drug pipelines to their offering.

Ventricular Arrhythmia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe.

A key objective of the Ventricular Arrhythmia Report is to understand the market and pipeline status of the drugs around the Ventricular Arrhythmia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline strategies. The Report provides the historical and forecasted sales of the drugs till 2018.

The Ventricular Arrhythmia Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Ventricular Arrhythmia.

While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Key Topics Covered:

1. Indication Overview

2. Market Drugs Landscape

3. Global API Manufacturers Assessment

4. Phase III Drugs Landscape

5. Drugs Market Data and Forecasted Sales Figure-2018

6. Marketed Drugs for Ventricular Arrhythmia

7. Phase III Drugs for Ventricular Arrhythmia

8. Discontinued Drugs for Ventricular Arrhythmia

9. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/cs9gkq/ventricular


© Business Wire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news
Date Title
06:22a MMG : LXML Sepon Supports Casting of Buddha Statue
06:22a Verizon Tops National Awards in Latest Mobile Network Performance Review; Other Carriers Make Solid Improvements, Including at State and Metro Levels
06:22a DEPARTMENT OF INDUSTRY AND SCIENCE AUSTRALIAN GO : Strengthening economic and technological ties with Israel
06:18a DISRUPTING THE DISRUPTERS : Singapore rattles sharing economy with rule change
06:16aDJNEWS HIGHLIGHTS : Top Financial Services News of the Day
06:16aDJNEWS HIGHLIGHTS : Top Energy News of the Day
06:16a VERIZON UNLIMITED ON THE NETWORK YOU DESERVE : RootMetrics® ranks Verizon highest in overall network performance for seventh time in a row
06:15aDJSingapore Jan CPI +0.6% On Year; Matches WSJ Poll
06:12a ODFJELL : Terminals continues development of possible ethylene export terminal at its Houston facility in Texas
06:12a ABM RESOURCES NL : Interim Financial Report for the Half-Year Ended 31 Dec 16
Latest news
Advertisement
Hot News 
0.13%EXXON MOBIL : Lowers Proved Reserve Estimates
Most Read News
02/22 Crude oil rises after report shows drop in stockpiles
02/22 ABB : Switzerland's ABB hit by $100 million South Korean fraud
02/22 PRUDENTIAL FINANCIAL : may hit Wells Fargo for account scandal costs-filing
02/22 TESLA : says Model 3 on track for volume production by September
02/22 Nissan says Ghosn to relinquish CEO role, Saikawa to take helm
Most recommended articles
12:16aDJNEWS HIGHLIGHTS : Top Energy News of the Day
02/22DJCruise Operator Wants You on a Slow Boat From China
02/22 Dollar drifts as impact from Fed minutes and Mnuchin fade, Aussie slips
02/22DJAYALA : Plans Record PHP185 Billion Capital Expenditure for 2017
02/22 Trump to seek jobs advice from firms that offshore U.S. work